Main Session
Oct 01
SS 45 - GU 10: Biomarker Breakthroughs in Prostate Cancer

361 - Predictive Role of Tumor Fraction and Copy Number Alteration Burden in mCRPC Patients Receiving Tandem Actinium-Lutetium Radionuclide Therapy

11:10am - 11:20am PT
Room 154

Presenter(s)

Mariam Amghar, PhD Headshot
Mariam Amghar, PhD - German Cancer Research Center (DKFZ), Heidelberg, Baden-Wurt